Search research articles
Contact Us
Filters
Showing results (31-40 of 67) with videos related to
Page
of 7
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
April 23, 2014
An empirically derived composite cognitive test score with improved power to track and evaluate treatments for preclinical Alzheimer's disease
Jessica B Langbaum, Suzanne B Hendrix, Napatkamon Ayutyanont, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2025
Basic Science and Pathogenesis
Christopher T Brown, Jessica Enos, Carolyn Langlois, et al.
Alzheimer'S Research & Therapy
|
May 29, 2020
The Alzheimer's Prevention Initiative Composite Cognitive Test: a practical measure for tracking cognitive decline in preclinical Alzheimer's disease
Jessica B Langbaum, Noel N Ellison, Angelika Caputo, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2023
Effects of the active amyloid beta immunotherapy CAD106 on PET measurements of amyloid plaque deposition in cognitively unimpaired APOE ε4 homozygotes
Marie-Emmanuelle Riviere, Jessica B Langbaum, R Scott Turner, et al.
JAMA Neurology
|
February 24, 2016
Cognitive Decline in a Colombian Kindred With Autosomal Dominant Alzheimer Disease: A Retrospective Cohort Study
Daniel C Aguirre-Acevedo, Francisco Lopera, Eliana Henao, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
January 11, 2020
Alzheimer's Prevention Initiative Generation Program: Development of an <i>APOE</i> genetic counseling and disclosure process in the context of clinical trials
Carolyn M Langlois, Angela Bradbury, Elisabeth M Wood, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
September 10, 2022
Why a clinical trial is as good as its outcome measure: A framework for the selection and use of cognitive outcome measures for clinical trials of Alzheimer's disease
Roos J Jutten, Kathryn V Papp, Suzanne Hendrix, et al.
Nature Reviews. Neurology
|
September 30, 2015
CAP--advancing the evaluation of preclinical Alzheimer disease treatments
Eric M Reiman, Jessica B Langbaum, Pierre N Tariot, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2025
Biomarkers
Ricquee Gonzalez-Green, Trisha L Walsh, Claire M Erickson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 23, 2025
Technology and Dementia Preconference
Angela R Bradbury, Brian L Egleston, Elisabeth Wood, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 67) with videos related to
Sort By:
Page
of 7
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
April 23, 2014
An empirically derived composite cognitive test score with improved power to track and evaluate treatments for preclinical Alzheimer's disease
Jessica B Langbaum, Suzanne B Hendrix, Napatkamon Ayutyanont, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2025
Basic Science and Pathogenesis
Christopher T Brown, Jessica Enos, Carolyn Langlois, et al.
Alzheimer'S Research & Therapy
|
May 29, 2020
The Alzheimer's Prevention Initiative Composite Cognitive Test: a practical measure for tracking cognitive decline in preclinical Alzheimer's disease
Jessica B Langbaum, Noel N Ellison, Angelika Caputo, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2023
Effects of the active amyloid beta immunotherapy CAD106 on PET measurements of amyloid plaque deposition in cognitively unimpaired APOE ε4 homozygotes
Marie-Emmanuelle Riviere, Jessica B Langbaum, R Scott Turner, et al.
JAMA Neurology
|
February 24, 2016
Cognitive Decline in a Colombian Kindred With Autosomal Dominant Alzheimer Disease: A Retrospective Cohort Study
Daniel C Aguirre-Acevedo, Francisco Lopera, Eliana Henao, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
January 11, 2020
Alzheimer's Prevention Initiative Generation Program: Development of an <i>APOE</i> genetic counseling and disclosure process in the context of clinical trials
Carolyn M Langlois, Angela Bradbury, Elisabeth M Wood, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
September 10, 2022
Why a clinical trial is as good as its outcome measure: A framework for the selection and use of cognitive outcome measures for clinical trials of Alzheimer's disease
Roos J Jutten, Kathryn V Papp, Suzanne Hendrix, et al.
Nature Reviews. Neurology
|
September 30, 2015
CAP--advancing the evaluation of preclinical Alzheimer disease treatments
Eric M Reiman, Jessica B Langbaum, Pierre N Tariot, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2025
Biomarkers
Ricquee Gonzalez-Green, Trisha L Walsh, Claire M Erickson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 23, 2025
Technology and Dementia Preconference
Angela R Bradbury, Brian L Egleston, Elisabeth Wood, et al.
Page
of 7